The synergic effect of BRAF<sup>V600E</sup> mutation and multifocality on central lymph node metastasis in unilateral papillary thyroid carcinoma-Reference-Cited by-同舟云学术

The synergic effect of BRAF^V600E mutation and multifocality on central lymph node metastasis in unilateral papillary thyroid carcinoma

Published:2018 Issue:1 Volume:65 Page:113-120
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Qu Hai-Jiang¹,Qu Xue-Yan²,Hu Ze¹,Lin Yan³,Wang Jun-Rong⁴,Zheng Chang-Fu⁵,Tan Zhuo⁶

Affiliation:

1. The Department of Thyroid and Breast, Taizhou Cancer Hospital, Wenling, Zhejiang, China

2. Nursing Department, The First People’s Hospital of Wenling, Wenling City, Zhejiang, China

3. Department of Laboratory Medicine, Taizhou Cancer Hospital, Wenling, Zhejiang, China

4. Department of Laboratory Medicine, Wenling Women’s and Children’s Hospital, Wenling, Zhejiang, China

5. Department of Ultrasound, Taizhou Cancer Hospital, Wenling, Zhejiang, China

6. Department of Head and Neck Surgery, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/65/1/65_EJ17-0110/_pdf

Reference43 articles.

1. 1 Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R (2013) Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol 2013: 965212.

2. 2 Moo TA, McGill J, Allendorf J, Lee J, Fahey T 3rd, et al. (2010) Impact of prophylactic central neck lymph node dissection on early recurrence in papillary thyroid carcinoma. World J Surg 34: 1187–1191.

3. 3 Mirallie E, Visset J, Sagan C, Hamy A, Le Bodic MF, et al. (1999) Localization of cervical node metastasis of papillary thyroid carcinoma. World J Surg 23: 970–973; discussion 973–974.

4. 4 Scheumann GF, Gimm O, Wegener G, Hundeshagen H, Dralle H (1994) Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 18: 559–567; discussion 567–568.

5. 5 Mazzaferri EL, Kloos RT (2001) Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86: 1447–1463.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospective application of a prediction model for lateral lymph node metastasis in papillary thyroid cancer patients with central lymph node metastasis;Frontiers in Endocrinology;2024-01-04

2. Gene mutations as predictors of central lymph mode metastasis in cN0 PTC: A meta‐analysis;Clinical Genetics;2023-11-20

3. Tetraspanin 1 regulates papillary thyroid tumor growth and metastasis through c‐Myc‐mediated glycolysis;Cancer Science;2023-09-26

4. Profile of BRAFV600E, BRAFK601E, NRAS, HRAS, and KRAS Mutational Status, and Clinicopathological Characteristics of Papillary Thyroid Carcinoma in Indonesian National Referral Hospital;The Application of Clinical Genetics;2023-05

5. Incidental Node Metastasis as an Independent Factor of Worse Disease-Free Survival in Patients with Papillary Thyroid Carcinoma;Cancers;2023-02-02